Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

GSK hopes real-world data flu app will go viral

Flumji has been developed by MIT Connection Science

- PMLiVE

Shire’s Dr Armin Reininger moves to Sobi

Appointed as senior vice president, head of global medical and scientific affairs

- PMLiVE

Brexit and Trump

The resulting cognitive dissonance from these events is making a lot of people feel very uncomfortable, but has the world really changed?

- PMLiVE

Brexit – a tough pill to swallow

What will be expected of the UK when the post-Brexit environment takes shape?

Biogen Idec building

Biogen proffers new data to support high-priced Spinraza

Trial demonstrates statistically-significant risk reduction in paediatric SMA for potential blockbuster drug

Novartis building

Novartis takes biosimilar delay complaint to Supreme Court

Seeks to overturn US law that requires 180-day launch delay after regulatory approval

- PMLiVE

Healthcare comms network GLOBALHealthPR expands into Asia

Newly-launched Asia-Pacific headquarters will be led by James Yi

- PMLiVE

Albumedix appoints Dr Giles Campion as CMO

He brings experience from Novartis and BioMarin

Novo signs personalised digital health deal in diabetes

Will work with Glooko on jointly-developed and branded solutions

- PMLiVE

GPI appoints commercial director

Alan Stewart joins the life science management consultancy's executive team

- PMLiVE

Gilead’s Hepatitis B therapy Vemlidy granted EU approval

Treatment shows similar efficacy to the firm's Viread at one-tenth of dosage

- PMLiVE

Merck pays Vertex $230m upfront for cancer programmes

Licences four DNA damage and repair programmes with first-in-class or best-in-class potential

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links